Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 3/20 | 0.41 |
| ▸ | RAD52 | P43351 | 3/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | GFER | P55789 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.33 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.33 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methylamine SCHEMBL21065237 | 0.83 | GAA (0.46) | GAARAD52SMN1; SMN2MAPTGFER | |
| SCHEMBL1615269 | 0.83 | ALOX15 (0.50) | ALOX15 | |
| SCHEMBL577052 | 0.83 | CHRNA7 (0.48) | GAARAD52SMN1; SMN2MAPTGFER | |
| SCHEMBL262312 | 0.83 | — | — | |
| SCHEMBL84808 | 0.83 | CHRNA7 (0.48) | GAARAD52SMN1; SMN2MAPTGFER | |
| SCHEMBL6657817 | 0.83 | CHRNA7 (0.48) | GAARAD52SMN1; SMN2MAPTGFER | |
| SCHEMBL577415 | 0.83 | CHRNA7 (0.48) | GAARAD52SMN1; SMN2MAPTGFER | |
| SCHEMBL5011399 | 0.83 | — | — | |
| Ammonia Solution, Strong SCHEMBL4249875 | 0.79 | — | — | |
| Hydrochloric Acid SCHEMBL14482129 | 0.79 | CHRNA7 (0.46) | GAARAD52SMN1; SMN2MAPTGFER |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022148317-A1 | 2-AMINOPYRIMIDINE COMPOUND AND PHARMACEUTICAL COMPOSITION THEREOF AND APPLICATION THEREOF | 广州市力鑫药业有限公司 | 2022-07-14 | — | — | WO | disclosed |
| US-9714245-B2 | Carboline compounds usable in the treatment of neurodegenerative diseases | ALZPROTECT (FR) | 2017-07-25 | — | — | US | disclosed |
| US-20160152610-A1 | Carboline Compounds Usable in The Treatment of Neurodegenerative Diseases | INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (FR) | 2016-06-02 | — | — | US | disclosed |
| US-20120329661-A1 | Isotope Labeling-Assisted Quantification (iLAQ) of Biological Compounds | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH | 2012-12-27 | — | — | US | disclosed |
| US-8080500-B2 | Amine tungstates and lubricant compositions | KING INDUSTRIES, INC. (US) | 2011-12-20 | — | — | US | disclosed |
| US-7820602-B2 | Amine tungstates and lubricant compositions | KING INDUSTRIES, INC. (US) | 2010-10-26 | — | — | US | disclosed |
| US-20090306376-A1 | OPTICAL RECORDING MEDIUM AND COMPOUND USED FOR THE SAME | MITSUI CHEMICALS, INC. (JP) | 2009-12-10 | — | — | US | disclosed |
| US-20090029888-A1 | AMINE TUNGSTATES AND LUBRICANT COMPOSITIONS | KING INDUSTRIES, INC. | 2009-01-29 | — | — | US | disclosed |
| US-20080194440-A1 | AMINE TUNGSTATES AND LUBRICANT COMPOSITIONS | RAVICHANDRAN RAMANATHAN | 2008-08-14 | — | — | US | disclosed |
| US-20070054084-A1 | Optical recording medium and compound used for the same | MITSUI CHEMICALS, INC. (JP) | 2007-03-08 | — | — | US | disclosed |
| US-20070042917-A1 | Amine Tungstates and Lubricant Compositions | KING INDUSTRIES, INC. | 2007-02-22 | — | — | US | disclosed |
| EP-1672626-A1 | OPTICAL RECORDING MEDIUM AND COMPOUND USED IN THE OPTICAL RECORDING MEDIUM | Mitsui Chemicals, Inc. (JP) | 2006-06-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090306376-A1 | OPTICAL RECORDING MEDIUM AND COMPOUND USED FOR THE SAME | CACNA1B, KCNN4, KCNN2 | GAA 4637/4885RAD52 3513/4885SMN1; SMN2 728/4885 |
| US-20120329661-A1 | Isotope Labeling-Assisted Quantification (iLAQ) of Biological Compounds | SRMS, QPCTL, NUP155 | GAA 1845/4885RAD52 3606/4885SMN1; SMN2 4653/4885 |
| US-20160152610-A1 | Carboline Compounds Usable in The Treatment of Neurodegenerative Diseases | SNCA, PARK7, HTT | GAA 104/4885RAD52 4632/4885SMN1; SMN2 20/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.